Seres Therapeutics, Inc. - COMMON STOCK (MCRB)

Historical Holders from Q2 2015 to Q1 2025

Symbol
MCRB on Nasdaq
CUSIP
81750R102
Type / Class
Equity / COMMON STOCK
Shares outstanding
170M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
63.1M
Holdings value
$52.5M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
70
Number of buys
26
Number of sells
-32
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Seres Therapeutics, Inc. - COMMON STOCK (MCRB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 12.8% $15.1M 21.8M FMR LLC Dec 31, 2024

Institutional Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 46.9K $32.8K -$11.9K $0.70 5
2024 Q4 63.1M $52.5M -$351K $0.83 70
2024 Q3 63.4M $60M -$4.73M $0.95 74
2024 Q2 69.1M $50M -$12.2M $0.72 90
2024 Q1 85.7M $66.3M -$8.85M $0.77 95
2023 Q4 70.1M $98.2M -$45M $1.40 101
2023 Q3 107M $256M -$22.5M $2.38 132
2023 Q2 112M $538M +$33.9M $4.79 138
2023 Q1 105M $594M -$2.08M $5.67 122
2022 Q4 105M $588M +$1.17M $5.60 123
2022 Q3 98.1M $629M +$109M $6.42 112
2022 Q2 89.3M $306M +$47.1M $3.43 115
2022 Q1 75.4M $537M -$11.2M $7.12 124
2021 Q4 76.9M $641M -$21.5M $8.33 138
2021 Q3 79.5M $554M -$221M $6.96 125
2021 Q2 66.6M $1.58B -$105M $23.85 138
2021 Q1 74.8M $1.54B +$74.9M $20.59 147
2020 Q4 71.2M $1.75B +$153M $24.50 141
2020 Q3 85.8M $2.43B +$415M $28.31 110
2020 Q2 72M $342M +$20.3M $4.76 90
2020 Q1 65.5M $234M +$6.97M $3.57 69
2019 Q4 65.9M $227M +$4.75M $3.45 74
2019 Q3 64.3M $258M +$14.7M $4.01 69
2019 Q2 61.5M $198M +$89.3M $3.22 82
2019 Q1 33.4M $229M +$13.1M $6.87 74
2018 Q4 29.4M $133M -$2.13M $4.52 62
2018 Q3 31.8M $242M +$1.35M $7.59 66
2018 Q2 31.8M $274M -$2.87M $8.60 74
2018 Q1 32.3M $237M +$910K $7.34 76
2017 Q4 32.1M $325M +$13.2M $10.14 84
2017 Q3 18.1M $290M +$9.43M $16.04 77
2017 Q2 28.1M $318M -$4.53M $11.30 70
2017 Q1 28.8M $325M -$6.11M $11.27 77
2016 Q4 31.1M $308M -$7.9M $9.90 89
2016 Q3 31.2M $383M -$53.6M $12.29 92
2016 Q2 18.8M $547M +$53.8M $29.05 88
2016 Q1 30.9M $822M +$43.1M $26.56 76
2015 Q4 15.2M $533M +$58.4M $35.09 66
2015 Q3 13.6M $401M +$65.1M $29.64 58
2015 Q2 11.4M $471M +$461M $41.50 45